COVID-19 Vaccine: Serum Institute Gets DCGI Nod To Resume Trials
New Delhi: The Drugs Controller General of India (DCGI) has given permission to Serum Institute of India, a Pune-based vaccine maker, to resume the Phase 2 and Phase 3 clinical trials of the COVID-19 vaccine in the country.
DCGI had halted…